NCT07218341 2026-03-24
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Eli Lilly and Company
Phase 4 Not yet recruiting
Clinical Trials
12 trialsNCT07474961 2026-03-16
BLOOD-dose
Rigshospitalet, Denmark
Phase 4 Not yet recruiting
NCT07426484 2026-02-23
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Phase 4 Not yet recruiting
NCT07167862 2026-01-23
PPPOCUS
University of California, Irvine
Phase 4 Not yet recruiting
NCT07320534 2026-01-08
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Gadjah Mada University
Phase 4 Not yet recruiting
NCT07264894 2025-12-04
ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Trial
Zhengzhou University
Phase 4 Not yet recruiting
NCT06956092 2025-05-02
Glofitamab
Zhengzhou University
Phase 4 Not yet recruiting
NCT06665737 2025-01-28
G-CSF in NHL
Department of Medical Services Ministry of Public Health of Thailand
Phase 4 Not yet recruiting
NCT06761911 2025-01-07
BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma
Dalian Medical University
Phase 4 Not yet recruiting
NCT05545202 2024-04-03
A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation
Pharmacosmos A/S
Phase 4 Not yet recruiting
NCT04790045 2023-10-03
LymBIO
IRCCS San Raffaele
Phase 4 Not yet recruiting
NCT05814848 2023-06-15
A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma
Changhai Hospital
Phase 4 Not yet recruiting